Serum Vascular Endothelial Growth Factor and COX-2/5-LOX Inhibition in Advanced Non-small Cell Lung Cancer: Cancer and Leukemia Group B 150304 Martin J. Edelman, MD, Lydia Hodgson, MS, Xiaofei Wang, PhD, Robert Christenson, MD, Scott Jewell, PhD, Everett Vokes, MD, Robert Kratzke, MD Journal of Thoracic Oncology Volume 6, Issue 11, Pages 1902-1906 (November 2011) DOI: 10.1097/JTO.0b013e31822a7383 Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions
FIGURE 1. CALGB 30203: Overall survival by baseline vascular endothelial growth factor (VEGF). Journal of Thoracic Oncology 2011 6, 1902-1906DOI: (10.1097/JTO.0b013e31822a7383) Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions